ADIL News

Adial Pharmaceuticals, which is developing a targeted therapy for alcohol use disorder based on an approved drug, raised $7.3 million by offering 1.46 million units at $5 per unit. The company had been on file to offer 1.5 million units at $5. Units consist of one share of common stock and one warrant exercisable at $6.25 per share. At IPO, Adial commands a market value of $32...read more

Adial Pharmaceuticals, which is developing a targeted therapy for alcohol use disorder based on an approved drug, lowered the proposed deal size for its upcoming IPO on Monday. The Charlottesville, VA-based company now plans to raise $7.5 million by offering 1.5 million shares at a price of $5. The company had previously filed to raise $14 million in December by offering 1.4...read more

Ten deals are expected to price next week, raising a combined $3.1 billion in proceeds, as this month gears up to be the busiest January in over eight years in terms of proceeds raised ($3.1 billion raised to date). The week will be headlined by the "Paypal of Brazil" PagSeguro Digital, expected to raise $1.8 billion in the largest IPO so far this year....read more

Four companies are targeting $247 million in the last active week of the 2017 IPO market. LexinFintech, a Chinese online microloan company, leads the pack with the largest deal of the week. Other IPOs include a life insurer and two small health care deals. While it is unusual to see so many IPOs this close to the holidays, we note that LexinFintech is likely pre-sold in China, and...read more